Latest News

Testing Parkinson's disease immune-based drugs: New models

Using powerful, newly developed cell culture and mouse models of sporadic Parkinson?s disease (PD), researchers have demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain. By intercepting the distorted and misfolded alpha-synuclein (?-syn) proteins that enter and propagate in neurons, creating aggregates, the researchers prevented the development of pathology and also reversed some of the effects of already-existing disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Three-minute assessment successfully identifies delirium in hospitalized elders

  • Largest study of Hispanics/Latinos finds depression, anxiety rates vary widely among groups

  • Stress-related inflammation may increase risk for depression

  • No relationship between moderate adolescent cannabis use, exam results or IQ, large study shows

  • Biochemical cause of seasonal depression (SAD) confirmed by researchers

  • For prescription drug addiction treatment, buprenorphine maintenance trumps detoxification

  • Key factor in transition from moderate to problem drinking

  • A rich vocabulary can protect against cognitive impairment

  • Even depressed people believe that life gets better

  • Tarantula venom illuminates electrical activity in live cells

  •